Scan to Download
One power score. Smarter investment decisions
Impact Biomedical Inc
IBO0.678USD
+0.020+2.98%
Close 09/19, 16:00（ET）Quotes delayed by 15 min
USD0.000After-hours (ET)
8.26MMarket Cap
LossP/E TTM
Impact Biomedical Inc
0.678
+0.020+2.98%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
Total revenue
--7.00K
----
----
----
----
----
----
----
----
----
--50.00K
----
--50.00K
----
Revenue
--7.00K
----
----
----
----
----
----
----
----
----
--50.00K
----
--50.00K
----
Cost of revenue
--299.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
Operating expenses
85.30%1.16M
31.00%1.01M
-23.18%875.00K
4.55%1.13M
-37.90%626.00K
-3.99%771.00K
9.52%1.14M
21.26%1.08M
26.00%1.01M
13.26%803.00K
--1.04M
--889.00K
--800.00K
--709.00K
R&D expenses
--75.00K
106.00%103.00K
----
-65.69%82.00K
-100.00%0.00
-72.07%50.00K
-11.30%463.00K
-27.58%239.00K
29.13%266.00K
6.55%179.00K
--522.00K
--330.00K
--206.00K
--168.00K
Depreciation, depletion, and amortization
3.23%288.00K
1.07%283.00K
-0.36%279.00K
0.36%281.00K
-0.36%279.00K
0.00%280.00K
0.72%280.00K
0.36%280.00K
0.72%280.00K
0.72%280.00K
--278.00K
--279.00K
--278.00K
--278.00K
Other operating expenses
----
----
---108.00K
----
----
----
----
----
----
----
----
----
----
----
Operating profit
-84.19%-1.15M
-31.00%-1.01M
23.18%-875.00K
-4.55%-1.13M
37.90%-626.00K
3.99%-771.00K
-15.05%-1.14M
-21.26%-1.08M
-34.40%-1.01M
-13.26%-803.00K
---990.00K
---889.00K
---750.00K
---709.00K
Net non-operating interest income (expenses)
Non-operating interest income
0.00%3.00K
0.00%3.00K
0.00%3.00K
0.00%3.00K
0.00%3.00K
0.00%3.00K
0.00%3.00K
0.00%3.00K
-96.67%3.00K
-96.88%3.00K
--3.00K
--3.00K
--90.00K
--96.00K
Non-operating interest expense
-0.38%260.00K
17.83%271.00K
116.00%270.00K
199.02%305.00K
125.00%261.00K
127.72%230.00K
-62.01%125.00K
10.87%102.00K
-16.55%116.00K
-24.06%101.00K
--329.00K
--92.00K
--139.00K
--133.00K
Special income (expenses)
---12.94M
----
---25.96M
--5.67M
----
----
100.00%0.00
----
----
----
---4.10M
----
----
----
Other non-operating income (expenses)
----
----
----
----
----
----
--0.00
----
----
--52.00K
--0.00
----
----
----
Income before tax
-1523.53%-14.35M
-28.06%-1.28M
-2049.09%-27.10M
460.32%4.24M
21.14%-884.00K
-17.55%-998.00K
76.72%-1.26M
-20.35%-1.18M
-40.30%-1.12M
-13.81%-849.00K
---5.42M
---978.00K
---799.00K
---746.00K
Income tax
----
----
--33.00K
----
----
--0.00
----
----
----
----
---1.88M
--1.26M
----
----
Income after tax
-1523.53%-14.35M
-28.06%-1.28M
-2051.70%-27.13M
460.32%4.24M
21.14%-884.00K
-17.55%-998.00K
64.35%-1.26M
47.36%-1.18M
-40.30%-1.12M
-13.81%-849.00K
---3.54M
---2.24M
---799.00K
---746.00K
Net income from continuous operations
-1523.53%-14.35M
-28.06%-1.28M
-2051.70%-27.13M
460.32%4.24M
21.14%-884.00K
-17.55%-998.00K
64.35%-1.26M
47.36%-1.18M
-40.30%-1.12M
-13.81%-849.00K
---3.54M
---2.24M
---799.00K
---746.00K
Net Income attributable to non-controlling interests
-220.00%-6.00K
69.44%-11.00K
3.85%-25.00K
60.00%-6.00K
126.32%5.00K
81.25%-36.00K
-550.00%-26.00K
77.61%-15.00K
71.64%-19.00K
-149.35%-192.00K
---4.00K
---67.00K
---67.00K
---77.00K
Net income attributable to controlling interests
-1513.72%-14.35M
-31.70%-1.27M
-2094.98%-27.11M
465.49%4.25M
19.33%-889.00K
-46.42%-962.00K
65.04%-1.23M
46.43%-1.16M
-50.55%-1.10M
1.79%-657.00K
---3.53M
---2.17M
---732.00K
---669.00K
Net income attributable to common shareholders
-1513.72%-14.35M
-31.70%-1.27M
-2094.98%-27.11M
465.49%4.25M
19.33%-889.00K
-46.42%-962.00K
65.04%-1.23M
46.43%-1.16M
-50.55%-1.10M
1.79%-657.00K
---3.53M
---2.17M
---732.00K
---669.00K
Basic earnings per share
-1423.04%-1.18
-25.56%-0.11
-2093.21%-2.36
465.38%0.37
19.34%-0.08
-46.42%-0.08
65.04%-0.11
46.43%-0.10
-50.56%-0.10
1.79%-0.06
---0.31
---0.19
---0.06
---0.06
Diluted earnings per share
-1423.04%-1.18
-25.56%-0.11
-2093.21%-2.36
158.38%0.06
19.34%-0.08
-46.42%-0.08
65.04%-0.11
46.43%-0.10
-50.56%-0.10
1.79%-0.06
---0.31
---0.19
---0.06
---0.06
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
